insights_auto
Why is EDIT down 2,41%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
1,82 $
arrow_downward
-2,41%(-0,045) 1D
1,89 $
arrow_upward
+3,56% (+0,065)bedtimeAfter hours
Closed: 17 նոյ, 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
1,90 $
High
1,94 $
Low
1,82 $
Mkt. cap
281,67 մլն
Avg. vol.
2,41 մլն
Volume
2,02 մլն
52-wk high
3,94 $
52-wk low
1,66 $
EPS
-0,62 $
Beta
2,09
Shares outstanding
154,34 մլն
No. of employees
87
Open
1,90 $
High
1,94 $
Low
1,82 $
Mkt. cap
281,67 մլն
Avg. vol.
2,41 մլն
Volume
2,02 մլն
52-wk high
3,94 $
52-wk low
1,66 $
EPS
-0,62 $
Beta
2,09
Shares outstanding
154,34 մլն
No. of employees
87
News stories
From web sources and news partners
BigGo Finance
·
22 րոպե առաջ
New York Stocks Slip a Day Before Nvidia Earnings; S&P 500, Nasdaq Fall for Fourth Straight Session
BigGo Finance
·
53 րոպե առաջ
Wall Street Split on 2027 S&P 500 Outlook: Wells Fargo's 8,200 vs. Morgan Stanley's 8,700
FXStreet
·
1 ժամ առաջ
Dow Jones Industrial Average slides on NSA outage, then Nvidia beats
www.tmgm.com
·
50 րոպե առաջ
NSA outage sends Dow Jones Industrial Average lower before Nvidia beats
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc